annual cash & cash equivalents:
$8.29B+$1.76B(+27.00%)Summary
- As of today (May 20, 2025), ELV annual cash & cash equivalents is $8.29 billion, with the most recent change of +$1.76 billion (+27.00%) on December 31, 2024.
- During the last 3 years, ELV annual cash & cash equivalents has risen by +$3.41 billion (+69.84%).
- ELV annual cash & cash equivalents is now at all-time high.
Performance
ELV Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$7.50B-$788.00M(-9.51%)Summary
- As of today (May 20, 2025), ELV quarterly cash & cash equivalents is $7.50 billion, with the most recent change of -$788.00 million (-9.51%) on March 31, 2025.
- Over the past year, ELV quarterly cash & cash equivalents has increased by +$1.27 billion (+20.46%).
- ELV quarterly cash & cash equivalents is now -31.31% below its all-time high of $10.92 billion, reached on September 30, 2023.
Performance
ELV quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ELV Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.0% | +20.5% |
| 3 y3 years | +69.8% | +21.7% |
| 5 y5 years | +67.9% | +40.3% |
ELV Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +69.8% | -31.3% | +21.7% |
| 5 y | 5-year | at high | +69.8% | -31.3% | +88.3% |
| alltime | all time | at high | +468.8% | -31.3% | +1957.0% |
ELV Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $7.50B(-9.5%) |
| Dec 2024 | $8.29B(+27.0%) | $8.29B(+5.4%) |
| Sep 2024 | - | $7.87B(+21.1%) |
| Jun 2024 | - | $6.50B(+4.4%) |
| Mar 2024 | - | $6.23B(-4.6%) |
| Dec 2023 | $6.53B(-11.7%) | $6.53B(-40.2%) |
| Sep 2023 | - | $10.92B(+9.3%) |
| Jun 2023 | - | $9.99B(-1.5%) |
| Mar 2023 | - | $10.14B(+37.3%) |
| Dec 2022 | $7.39B(+51.4%) | $7.39B(-16.7%) |
| Sep 2022 | - | $8.87B(+37.4%) |
| Jun 2022 | - | $6.46B(+4.8%) |
| Mar 2022 | - | $6.16B(+26.3%) |
| Dec 2021 | $4.88B(-15.0%) | $4.88B(-11.1%) |
| Sep 2021 | - | $5.49B(+4.4%) |
| Jun 2021 | - | $5.26B(-43.6%) |
| Mar 2021 | - | $9.33B(+62.4%) |
| Dec 2020 | $5.74B(+16.3%) | $5.74B(+44.1%) |
| Sep 2020 | - | $3.98B(-33.9%) |
| Jun 2020 | - | $6.03B(+12.8%) |
| Mar 2020 | - | $5.34B(+8.3%) |
| Dec 2019 | $4.94B(+25.5%) | $4.94B(+17.8%) |
| Sep 2019 | - | $4.19B(+2.7%) |
| Jun 2019 | - | $4.08B(-9.0%) |
| Mar 2019 | - | $4.48B(+13.9%) |
| Dec 2018 | $3.93B(+9.0%) | $3.93B(-7.7%) |
| Sep 2018 | - | $4.26B(-9.0%) |
| Jun 2018 | - | $4.68B(+1.1%) |
| Mar 2018 | - | $4.63B(+28.3%) |
| Dec 2017 | $3.61B(-11.4%) | $3.61B(-40.8%) |
| Sep 2017 | - | $6.10B(+33.7%) |
| Jun 2017 | - | $4.56B(-32.7%) |
| Mar 2017 | - | $6.77B(+66.2%) |
| Dec 2016 | $4.08B(+92.8%) | $4.08B(+60.1%) |
| Sep 2016 | - | $2.55B(+60.9%) |
| Jun 2016 | - | $1.58B(-5.6%) |
| Mar 2016 | - | $1.68B(-20.7%) |
| Dec 2015 | $2.11B(-1.8%) | $2.11B(+36.5%) |
| Sep 2015 | - | $1.55B(-0.3%) |
| Jun 2015 | - | $1.55B(+11.2%) |
| Mar 2015 | - | $1.40B(-35.1%) |
| Dec 2014 | $2.15B(+36.0%) | $2.15B(+25.3%) |
| Sep 2014 | - | $1.72B(-3.7%) |
| Jun 2014 | - | $1.78B(-9.5%) |
| Mar 2014 | - | $1.97B(+24.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $1.58B(-36.1%) | $1.58B(-27.6%) |
| Sep 2013 | - | $2.19B(+62.2%) |
| Jun 2013 | - | $1.35B(-19.1%) |
| Mar 2013 | - | $1.67B(-32.7%) |
| Dec 2012 | $2.48B(+12.4%) | $2.48B(+1.4%) |
| Sep 2012 | - | $2.44B(+25.0%) |
| Jun 2012 | - | $1.95B(-14.3%) |
| Mar 2012 | - | $2.28B(+3.5%) |
| Dec 2011 | $2.20B(+23.1%) | $2.20B(-12.2%) |
| Sep 2011 | - | $2.51B(+47.6%) |
| Jun 2011 | - | $1.70B(-29.2%) |
| Mar 2011 | - | $2.40B(+34.3%) |
| Dec 2010 | $1.79B(-62.9%) | $1.79B(-11.8%) |
| Jun 2010 | - | $2.03B(-42.5%) |
| Mar 2010 | - | $3.53B(-26.8%) |
| Dec 2009 | $4.82B(+120.5%) | $4.82B(+161.4%) |
| Sep 2009 | - | $1.84B(+6.8%) |
| Jun 2009 | - | $1.72B(-27.5%) |
| Mar 2009 | - | $2.38B(+8.9%) |
| Dec 2008 | $2.18B(-21.1%) | $2.18B(-3.8%) |
| Sep 2008 | - | $2.27B(-0.1%) |
| Jun 2008 | - | $2.27B(-10.9%) |
| Mar 2008 | - | $2.55B(-7.8%) |
| Dec 2007 | $2.77B(+6.4%) | $2.77B(-2.0%) |
| Sep 2007 | - | $2.82B(-32.8%) |
| Jun 2007 | - | $4.21B(+23.6%) |
| Mar 2007 | - | $3.40B(+30.7%) |
| Dec 2006 | $2.60B(-5.0%) | $2.60B(+16.7%) |
| Sep 2006 | - | $2.23B(+15.3%) |
| Jun 2006 | - | $1.93B(-9.6%) |
| Mar 2006 | - | $2.14B(-21.9%) |
| Dec 2005 | $2.74B(+88.0%) | $2.74B(+26.7%) |
| Sep 2005 | - | $2.16B(+10.8%) |
| Jun 2005 | - | $1.95B(+31.0%) |
| Mar 2005 | - | $1.49B(+2.3%) |
| Dec 2004 | $1.46B | $1.46B(+105.1%) |
| Sep 2004 | - | $710.60M(-34.8%) |
| Jun 2004 | - | $1.09B(+58.9%) |
| Mar 2004 | - | $686.30M(+2.4%) |
| Sep 2003 | - | $670.10M(+40.8%) |
| Jun 2003 | - | $475.90M(+2.6%) |
| Mar 2003 | - | $463.90M(-49.1%) |
| Sep 2002 | - | $912.00M(+37.0%) |
| Jun 2002 | - | $665.70M(+45.9%) |
| Mar 2002 | - | $456.30M(+25.2%) |
| Sep 2001 | - | $364.60M |
FAQ
- What is Elevance Health annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Elevance Health?
- What is Elevance Health annual cash & cash equivalents year-on-year change?
- What is Elevance Health quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Elevance Health?
- What is Elevance Health quarterly cash & cash equivalents year-on-year change?
What is Elevance Health annual cash & cash equivalents?
The current annual cash & cash equivalents of ELV is $8.29B
What is the all time high annual cash & cash equivalents for Elevance Health?
Elevance Health all-time high annual cash & cash equivalents is $8.29B
What is Elevance Health annual cash & cash equivalents year-on-year change?
Over the past year, ELV annual cash & cash equivalents has changed by +$1.76B (+27.00%)
What is Elevance Health quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ELV is $7.50B
What is the all time high quarterly cash & cash equivalents for Elevance Health?
Elevance Health all-time high quarterly cash & cash equivalents is $10.92B
What is Elevance Health quarterly cash & cash equivalents year-on-year change?
Over the past year, ELV quarterly cash & cash equivalents has changed by +$1.27B (+20.46%)